Patent · US Active

Reduction of in vivo analyte signal degradation using multiple metals

US11826143B2 · kind B2 · utility

0Cited by
5References
15Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 5, 2019
Grant dateNov 28, 2023
Priority date
Expiry dateApr 17, 2042

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61B2562/18
  • WIPO fieldMedical technology
  • WIPO sectorInstruments

Abstract

A sensor (e.g., an optical sensor) that may be implanted within a living animal (e.g., a human) and may be used to measure an analyte (e.g., glucose or oxygen) in a medium (e.g., interstitial fluid, blood, or intraperitoneal fluid) within the animal. The sensor may include a sensor housing, an analyte indicator covering at least a portion of the sensor housing, and a multiple metal protective system including multiple metals incorporated in and/or in close proximity to a surface of the analyte indicator that reduce deterioration of the analyte indicator.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.